Overview

A Study of Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV)

Status:
Recruiting
Trial end date:
2025-05-21
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy of rilematovir compared to placebo treatment with respect to the clinical outcome on the RSV Recovery Scale (RRS).
Phase:
Phase 3
Details
Lead Sponsor:
Janssen Research & Development, LLC